BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11242795)

  • 21. Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma.
    Tworek JA; Singleton TP; Schnitzer B; Hsi ED; Ross CW
    Am J Clin Pathol; 1998 Nov; 110(5):582-9. PubMed ID: 9802342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
    Ito M; Iida S; Inagaki H; Tsuboi K; Komatsu H; Yamaguchi M; Nakamura N; Suzuki R; Seto M; Nakamura S; Morishima Y; Ueda R
    Jpn J Cancer Res; 2002 Jun; 93(6):685-94. PubMed ID: 12079517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the immunoglobulin heavy chain gene of secondary diffuse large B-cell lymphoma that subsequently developed in four cases with B-cell chronic lymphocytic leukemia or lymphoplasmacytoid lymphoma (Richter syndrome).
    Nakamura N; Kuze T; Hashimoto Y; Hoshi S; Tominaga K; Sasaki Y; Shirakawa A; Sato M; Maeda K; Abe M
    Pathol Int; 2000 Aug; 50(8):636-43. PubMed ID: 10972862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
    Dunphy CH; Perkins SL
    Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
    Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCR4 expression in a case of cutaneous Richter's transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations.
    Nannini PR; Borge M; Mikolaitis VC; Abreu C; Morande PE; Zanetti SR; Oppezzo P; Palacios F; Ledesma I; Bezares RF; Giordano M; Gamberale R
    Eur J Haematol; 2011 Jul; 87(1):80-6. PubMed ID: 21443542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathologic characteristics of bone marrow for 
CD5 positive small B cell lymphoma].
    Peng S; Zhu F; You S; Gong M; Wen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):374-9. PubMed ID: 27241147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
    Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
    Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.
    Yin CC; Lin P; Carney DA; Handy BC; Rassidakis GZ; Admirand JH; Keating MJ; Medeiros LJ
    Am J Clin Pathol; 2005 Apr; 123(4):594-602. PubMed ID: 15743747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia.
    Geisler CH; Larsen JK; Hansen NE; Hansen MM; Christensen BE; Lund B; Nielsen H; Plesner T; Thorling K; Andersen E
    Blood; 1991 Oct; 78(7):1795-802. PubMed ID: 1717071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
    Pangalis GA; Angelopoulou MK; Vassilakopoulos TP; Siakantaris MP; Kittas C
    Semin Hematol; 1999 Apr; 36(2):104-14. PubMed ID: 10319379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma.
    Yoshino T; Tanaka T; Sato Y
    J Clin Exp Hematop; 2020 Dec; 60(4):124-129. PubMed ID: 32249238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia.
    Salem DA; Stetler-Stevenson M
    Methods Mol Biol; 2019; 2032():311-321. PubMed ID: 31522426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-cell chronic lymphocytic leukaemia stage 0. An immunophenotypic study of 66 cases and comparison with B small cell lymphomas.
    Stramignoni A; Valente G; Geuna M; Stramignoni D; Novero D; Ragona R; Resegotti L; Palestro G
    Eur J Haematol; 1994 Mar; 52(3):145-51. PubMed ID: 8168593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Sun Y; Wang SA; Sun T
    Cytometry B Clin Cytom; 2018 Jan; 94(1):148-150. PubMed ID: 28109040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23.
    Dorfman DM; Pinkus GS
    Mod Pathol; 1994 Apr; 7(3):326-31. PubMed ID: 8058704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
    Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M
    Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.